Origent Data Sciences | Managing Drug Development Risk through Better Foresight

Unlocking the Next Frontier of Health Data

Origent's AI health companion transforms unstructured patient narratives into real-time, actionable intelligence—creating a new category of health data that drives earlier diagnosis, smarter care, and scalable value across healthcare.

Join the Journey

A Second Chance at Registration

Origent leverages advanced predictive analytics to rescue failed drug programs in ALS, Alzheimer’s, and other neurodegenerative diseases.

Learn More About Drug Rescue

Managing Drug Development Risk through Better Foresight

Predicting patient-level dynamics allows researchers, drug developers, and investors better manage risks and reduce the costs of drug discovery.

Our Mission

Unparalleled ALS Predictive Modeling Capabilities

Origent's suite of predictive models accurately predict the progression of ALS and ALS symptoms.

See our ALS Models

Informed Discovery

Origent's clinical trial analysis tools help biotech firms conduct more cost efficient clinical trials and inform new experiments.

Faster Insight for Biotech

Fail Faster

We help pharmaceutical companies identify the most promising prospects in their drug development pipeline earlier, to eliminate failing projects and better prioritize scarce resources.

Earlier Knowledge for Pharma

Invest Confidently

Origent has a unique method for helping biotech investors evaluate clinical trial data during due diligence.

Venture Capital and Investors